|
|
Name: |
Cormorant Asset Management LLC |
City: |
BOSTON |
State: |
MA |
Zip: |
02110 |
|
|
|
Achive
data |
View
Filing Period: |
|
|
|
|
|
|
Download |
|
|
|
|
|
Free Registration Required For Full Results
|
|
|
Holdings
Found :
52 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position Rank |
New/Closed Postion |
Last Close |
Value |
Shares Held |
% of Portfolio |
Value Change |
Change In Shares Held |
% of Company |
Industry |
|
MLTX |
Multisys Language Solutions... |
1 |
- |
$0.00 |
$331,866,000 |
8,494,151 |
25.13% |
-128,092,000 |
0 |
13.506 |
N/A |
|
EWTX |
Edgewise Therapeutics, Inc. |
2 |
- |
$13.17 |
$90,244,000 |
4,101,992 |
6.83% |
-710,000 |
695,458 |
3.977 |
N/A |
|
BBIO |
Bridgebio Pharma, Inc. |
3 |
- |
$44.86 |
$69,140,000 |
2,000,000 |
5.23% |
25,236,000 |
400,000 |
1.15 |
N/A |
|
ACLX |
Arcellx, Inc. |
4 |
- |
$0.00 |
$68,880,000 |
1,050,000 |
5.22% |
-30,817,000 |
-250,000 |
1.953 |
N/A |
|
PRAX |
Praxis Precision Medicines,... |
5 |
- |
$0.00 |
$66,083,000 |
1,745,000 |
5% |
-64,227,000 |
51,781 |
3.331 |
N/A |
|
NAMS |
Newamsterdam Pharma Ord Shs |
6 |
- |
$0.00 |
$57,828,000 |
2,825,000 |
4.38% |
-25,697,000 |
-425,000 |
3.464 |
N/A |
|
JANX |
Janux Therapeutics, Inc. |
7 |
- |
$0.00 |
$54,000,000 |
2,000,000 |
4.09% |
-58,434,000 |
-100,000 |
3.834 |
N/A |
|
EYPT |
EyePoint Pharmaceuticals Inc |
8 |
- |
$0.44 |
$45,122,000 |
8,325,000 |
3.42% |
-16,899,000 |
0 |
5.801 |
Biotechnology |
|
INSM |
Insmed Inc |
9 |
- |
$99.49 |
$40,052,000 |
525,000 |
3.03% |
-4,824,000 |
-125,000 |
0.276 |
Biotechnology |
|
DRUG |
Bright Minds Biosciences Or... |
10 |
- |
$0.00 |
$38,210,000 |
1,059,331 |
2.89% |
53,000 |
0 |
11.77 |
N/A |
|
HLXB |
Helix Acquisition Corp. Ii |
11 |
- |
$10.65 |
$32,872,000 |
2,909,000 |
2.49% |
2,327,000 |
0 |
15.81 |
N/A |
|
CNTA |
Centessa Pharmaceuticals Plc |
12 |
- |
$0.00 |
$32,522,000 |
2,261,600 |
2.46% |
-10,385,000 |
-300,000 |
1.726 |
N/A |
|
MRUS |
Merus Nv |
13 |
- |
$52.99 |
$31,147,000 |
740,000 |
2.36% |
30,000 |
0 |
1.033 |
N/A |
|
RAPP |
Rapport Therapeutics, Inc. |
14 |
- |
$11.43 |
$29,497,000 |
2,940,921 |
2.23% |
-22,675,000 |
0 |
8.04 |
N/A |
|
AXSM |
Axsome Therapeutics, Inc. |
15 |
- |
$103.36 |
$29,158,000 |
250,000 |
2.21% |
1,660,000 |
-75,000 |
0.528 |
N/A |
|
PHVS |
Pharvaris N V Ord Shs |
16 |
- |
$0.00 |
$23,023,000 |
1,466,460 |
1.74% |
-5,089,000 |
0 |
0.354 |
N/A |
|
GHRS |
Gh Research Ord Shs |
17 |
- |
$0.00 |
$22,165,000 |
2,009,482 |
1.68% |
18,014,000 |
1,416,439 |
4.114 |
N/A |
|
ARQT |
Arcutis Biotherapeutics, Inc. |
18 |
- |
$13.74 |
$21,114,000 |
1,350,000 |
1.6% |
-4,308,000 |
-475,000 |
1.005 |
N/A |
|
TARS |
Tarsus Pharmaceuticals, Inc. |
19 |
- |
$0.00 |
$20,548,000 |
400,000 |
1.56% |
-7,137,000 |
-100,000 |
0.903 |
N/A |
|
SBTX |
Silverback Therapeutics, Inc. |
20 |
- |
$0.00 |
$20,128,000 |
1,600,000 |
1.52% |
14,853,000 |
1,100,000 |
0.924 |
N/A |
|
CRNX |
Crinetics Pharmaceuticals, ... |
21 |
- |
$29.96 |
$20,124,000 |
600,000 |
1.52% |
-31,006,000 |
-400,000 |
0.652 |
N/A |
|
CGON |
CG Oncology, Inc |
22 |
- |
$25.95 |
$18,980,000 |
775,000 |
1.44% |
-3,247,000 |
0 |
1.174 |
N/A |
|
CRGX |
Cargo Therapeutics, Inc. |
23 |
- |
$0.00 |
$13,762,000 |
3,381,277 |
1.04% |
-3,291,000 |
2,198,714 |
0 |
N/A |
|
ABVX |
Abivax S.A |
24 |
- |
$7.40 |
$13,313,000 |
2,130,000 |
1.01% |
-2,279,000 |
0 |
3.435 |
N/A |
|
ALMS |
Alumis Inc. |
25 |
- |
$3.02 |
$13,185,000 |
2,147,396 |
1% |
-3,694,000 |
0 |
4.548 |
N/A |
|
CRBP |
Corbus Pharmaceuticals Hold... |
26 |
- |
$7.40 |
$12,611,000 |
2,375,000 |
0.95% |
-15,414,000 |
0 |
1.896 |
N/A |
|
RNA |
Avidity Biosciences, Inc. |
27 |
- |
$29.03 |
$11,808,000 |
400,000 |
0.89% |
-18,726,000 |
-650,000 |
0.296 |
N/A |
|
MTSR |
Metsera, Inc. |
28 |
New |
$28.59 |
$10,888,000 |
400,000 |
0.82% |
10,888,000 |
400,000 |
0.381 |
N/A |
|
ENGN |
Engene Holdings Inc. |
29 |
- |
$3.66 |
$10,410,000 |
2,323,595 |
0.79% |
-5,042,000 |
0 |
5.261 |
N/A |
|
BIOA |
Bioage Labs, Inc. |
30 |
- |
$4.20 |
$9,887,000 |
2,629,529 |
0.75% |
-5,338,000 |
0 |
7.341 |
N/A |
|
RYTM |
Rhythm Pharmaceuticals, Inc. |
31 |
- |
$62.73 |
$7,946,000 |
150,000 |
0.6% |
-14,446,000 |
-250,000 |
0.211 |
N/A |
|
OKUR |
OnKure Therapeutics, Inc. |
32 |
- |
$2.40 |
$7,902,000 |
1,837,739 |
0.6% |
-7,903,000 |
0 |
14.528 |
N/A |
|
BMEA |
Biomea Fusion, Inc. |
33 |
- |
$1.81 |
$7,606,000 |
3,570,872 |
0.58% |
-6,249,000 |
0 |
12.412 |
N/A |
|
KRRO |
Korro Bio |
34 |
- |
$0.00 |
$6,621,000 |
380,303 |
0.5% |
6,621,000 |
380,303 |
1.13 |
N/A |
|
PCVX |
Vaxcyte, Inc. |
35 |
- |
$0.00 |
$6,608,000 |
175,000 |
0.5% |
-28,183,000 |
-250,000 |
0.128 |
N/A |
|
AARD |
Aardvark Therapeutics, Inc. |
36 |
New |
$0.00 |
$6,009,000 |
800,189 |
0.45% |
6,009,000 |
800,189 |
3.688 |
N/A |
|
MBX |
Mbx Biosciences, Inc. |
37 |
- |
$0.00 |
$5,166,000 |
700,000 |
0.39% |
-7,735,000 |
0 |
2.095 |
N/A |
|
ELVN |
Enliven Therapeutics Ord Shs |
38 |
- |
$0.00 |
$4,920,000 |
250,000 |
0.37% |
-705,000 |
0 |
0.498 |
N/A |
|
PLRX |
Pliant Therapeutics, Inc. |
39 |
New |
$0.00 |
$4,050,000 |
3,000,000 |
0.31% |
4,050,000 |
3,000,000 |
4.36 |
N/A |
|
KALA |
Kala Pharmaceuticals, Inc. |
40 |
- |
$4.62 |
$3,455,000 |
603,027 |
0.26% |
-730,000 |
0 |
13.081 |
N/A |
|
STOK |
Stoke Therapeutics, Inc. |
41 |
- |
$11.63 |
$1,690,000 |
254,161 |
0.13% |
-1,113,000 |
0 |
0.406 |
N/A |
|
BHVN |
Biohaven Ltd. |
42 |
- |
$14.09 |
$240,000 |
10,000 |
0.02% |
-1,834,000 |
-45,539 |
0.011 |
N/A |
|
URGN |
Urogen Pharma Ltd. |
51 |
Closed |
$13.49 |
$0 |
0 |
0% |
-3,195,000 |
-300,000 |
0 |
N/A |
|
SEPN |
Septerna, Inc. |
44 |
Closed |
$10.51 |
$0 |
0 |
0% |
-12,824,000 |
-560,000 |
0 |
N/A |
|
IBRX |
ImmunityBio, Inc |
50 |
Closed |
$2.70 |
$0 |
0 |
0% |
-7,680,000 |
-3,000,000 |
0 |
N/A |
|
RAPT |
Rapt Therapeutics, Inc. |
43 |
Closed |
$1.03 |
$0 |
0 |
0% |
-316,000 |
-200,000 |
0 |
N/A |
|
YMAB |
Y-Mabs Therapeutics Inc |
49 |
Closed |
$4.70 |
$0 |
0 |
0% |
-3,328,000 |
-425,000 |
0 |
N/A |
|
VYNE |
VYNE Therapeutics Inc |
48 |
Closed |
$0.22 |
$0 |
0 |
0% |
-4,671,000 |
-1,394,336 |
0 |
N/A |
|
AVBP |
Arrivent Biopharma, Inc. |
47 |
Closed |
$22.91 |
$0 |
0 |
0% |
-15,597,000 |
-585,462 |
0 |
N/A |
|
VERV |
Verve Therapeutics, Inc. |
46 |
Closed |
$0.00 |
$0 |
0 |
0% |
-1,974,000 |
-350,000 |
0 |
N/A |
|
ARTV |
Artiva Biotherapeutics, Inc. |
52 |
Closed |
$0.00 |
$0 |
0 |
0% |
-1,045,000 |
-103,633 |
0 |
N/A |
|
OMER |
Omeros Corp |
45 |
Closed |
$3.20 |
$0 |
0 |
0% |
-2,964,000 |
-300,000 |
0 |
Drug Manufacturers - ... |
|